RXPA 380
RXPA 380 is a C-terminal specific angiotensin-converting enzyme (ACE) inhibitor with a Ki of 3 nM. RXPA 380 inhibits C-domain mutants of human recombinant ACE with an IC50 of 2.5 nM[1].
Product Specifications
CAS Number
564479-79-4
UNSPSC
12352005
Target
Angiotensin-converting Enzyme (ACE)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/rxpa-380.html
Solubility
10 mM in DMSO
Smiles
O=C(O)[C@H](CC1=CNC2=CC=CC=C12)NC(C3C(P([C@@H](NC(OCC4=CC=CC=C4)=O)CC5=CC=CC=C5)(O)=O)CCC3)=O
Molecular Formula
C33H36N3O7P
Molecular Weight
617.63
References & Citations
[1]Georgiadis D, et al. Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: insights from selective inhibitors. Circ Res. 2003 Jul 25;93 (2) :148-54.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6456357-01 0.1 mL
GLP-1 Receptor (Glucagon-like peptide 1 Receptor, GLP-1 Receptor, GLP-1-R, GLP-1R, GLP1R) (MaxLight 650)
Sign In for Pricing
View Details MBS6456357-02 5x 0.1 mL
GLP-1 Receptor (Glucagon-like peptide 1 Receptor, GLP-1 Receptor, GLP-1-R, GLP-1R, GLP1R) (MaxLight 650)
Sign In for Pricing
View Details